Notify me when Helix Holdings II LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| HLXB | Helix Acquisition Corp. II | Class A ordinary shares, $0.0001 par value per share | 31.59% | $80M | 7.39M | Bihua Chen | Feb 28, 2025 | ||
| BBOT | BridgeBio Oncology Therapeutics, Inc. | Common Stock | 22.6% | $169M | 17.9M | Bihua Chen | Aug 11, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|